2m 2m 2m 2m 2m 2m 2m
Zevra (ZVRA)
NASDAQ
$11.06+$0.10 (+0.95%)
Price as of Jun 03, 2026 8:00 PM EDT- $685.1MMarket Cap
- 22.66%1-Year Change
- BiotechnologyIndustry
Zevra (ZVRA)
$11.06+$0.10 (+0.95%)
ZVRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.96 | ||
Change | -$0.61 (-5.31%) | ||
Open | $11.08 | ||
High | $11.10 | ||
Low | $10.87 | ||
Previous Close | $10.88 | ||
Volume | 1,582,750 | ||
30-Day Average Volume | 2,025,985 | ||
1-Week Change | 5.43% | ||
1-Month Change | 8.04% | ||
1-Year Change | 22.66% | ||
3-Year Change | 115.87% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 59.1M | ||
Total Assets | $278.6M | ||
Market Cap | $685.1M | ||
Enterprise Value | $589.5M | ||
Period: QTR TTM FY | |||
Revenue | $36.2M | ||
Net Income | $37.9M | ||
Free Cash Flow | $6.1M | ||
EBIT | $44.8M | ||
EBITDA | $45.2M | ||
Net Working Capital | $182.9M | ||
EPS | $0.60 | ||
Enterprise Value/EBITDA | 13 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 3 | ||
P/E | 19 | ||
PEG | 0 | ||
Price/Free Cash Flow | 112 | ||
Price/Operating Cash Flow | 112 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue